IJTLD OPEN (ISSN: 3005-7590) is open access and fully compliant with Plan S.
Articles submitted to IJTLD OPEN are evaluated solely on scientific merit. IJTLD OPEN has the same values as the IJTLD, with an identical Editorial Board, peer review process and acceptance criteria.
We publish high impact research for the continuing education of academics, clinicians and other health personnel working on respiratory diseases and lung health. Our scope includes translational, clinical, epidemiological and programmatic research to find health solutions for these conditions, including the development of vaccines, diagnostics and medicines for the prevention, management and control of TB and other areas of lung health such as asthma, bronchiectasis, COVID-19, COPD and the hazards of tobacco and air pollution.
IJTLD OPEN is open access and free to read. Also, authors retain copyright and can freely distribute the PDF or upload it to any website. As a consequence, open access articles are highly downloaded and more highly cited.
Click the links below to read our content on PubMed Central, Ingenta.com or see the Table of Contents for each issue.
We invite authors with OA funding to submit their papers (including Editorials, Original Articles, Letters and Case Series) to IJTLD OPEN.
We welcome submissions on the development of vaccines, diagnostics and medicines for the prevention, management and control of TB and all other respiratory diseases.
This includes basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
For all queries please e-mail the Editorial Office
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD OPEN has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available on Ingenta.com and we will have regular mailings to highlight the latest sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic
Letter to the editors of the IJTLD which assesses the impact of lockdown (shelter-in-place orders) on TB case notifications.
How to manage children if a second wave of COVID-19 occurs
A letter to the editors of the IJTLD arguing that we should avoid restrictions on children’s lives during any new waves of COVID-19 – and avoid school closures.
Adapting TB services during the COVID-19 pandemic in Mumbai, India
A letter to the Editors of the IJTLD on adaptations to TB services that could help ensure continuity of services for RR/MDR-TB during COVID-19.
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria
Letter to the editors giving an early view into the impact of COVID-19 on TB diagnosis in Nigeria, a high burden setting for TB.
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease
A letter to the editors of the IJTLD which highlights the need to mitigate the risk of researchers being exposed to TB and other airborne pathogens.
COVID-19 and TB control in immigrant communities
Letter to the editors highlighting the disparity of impact of COVID-19 and TB on immigrant communities and the need to have affordable healthcare.